What one share of Endra Life Sciences holds
We were incorporated as a Delaware corporation in 2007. We are developing a next-generation enhanced ultrasound technology platform—Thermo- Acoustic Enhanced
Endra Life Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$5.40 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$4.42 |
| Cash and investments | $1.16 |
| Book value | $4.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | — | −$56.94 | $0.08 | −$36.70 | — | — |
| 2025 | — | −$8.93 | $0.02 | −$6.61 | — | $1.92 |
Common questions about Endra Life Sciences
How much does one share of Endra Life Sciences earn?
Over the last 12 months, Endra Life Sciences lost $5.40 for each share.
Does Endra Life Sciences pay a dividend?
Endra Life Sciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Endra Life Sciences’s book value per share?
Endra Life Sciences’s book value is $4.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Endra Life Sciences have?
Each share of Endra Life Sciences has $1.16 of cash and investments, as of June 30, 2026.
What is Endra Life Sciences’s free cash flow per share?
−$4.42 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.